Unlike conventional culture methods that rely solely on the growth factor interleukin (IL)-2, NeoScreen is based on the early exposure of TILs grown from whole tumor fragments or from dissociated tumor cells to antigens of choice15 loaded on competent autologous antigen-presenting cells (APCs) (Fig. 1a). This evidence concerns the gene IL2 and neoplasm.